BioLineRx
BLRX
HK$20.60
Share price
-9.86%
Change (1 day)
220.90%
Change (1 year)
Categories
EPS for BioLineRx (BLRX)
EPS in 2023 (TTM): -HK$7.06
According to BioLineRx's latest financial reports the company's current EPS (TTM) is -HK$7.00. In 2022 the company made an earnings per share (EPS) of -HK$3.50 an increase over its 2021 EPS that were of -HK$4.66.
EPS history for BioLineRx from 2010 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -HK$7.06 | 101.69% |
| 2022 | -HK$3.50 | -25% |
| 2021 | -HK$4.66 | -66.67% |
| 2020 | -HK$13.99 | -29.41% |
| 2019 | -HK$19.82 | -19.05% |
| 2018 | -HK$24.49 | -22.22% |
| 2017 | -HK$31.49 | -3.57% |
| 2016 | -HK$32.65 | -0% |
| 2015 | -HK$32.65 | -17.65% |
| 2014 | -HK$39.65 | -55.26% |
| 2013 | -HK$88.63 | -36.9% |
| 2012 | -HK$140.46 | 11.81% |
| 2011 | -HK$125.62 | -737.01% |
| 2010 | HK$19.72 |